EGFR- and ALK-targeted treatment: present and future
EGFR- and ALK-targeted treatment: present and fu
Immunotherapy: the emerging paradigm of cure
Immunotherapy: the emerging paradigm of cure
Preface – Preceptorship Shanghai
Preceptorship Shanghai Caicun Zhou, MD, PhD,
臨床試験の倫理的考慮および治験責任医師の責任
臨床試験の倫理的考慮および治験責任医師の責任 はじめに 倫理は、良好な行為を支持する倫理上の原理として
バイオマーカーに基づく臨床試験：試験のデザインおよび規制上の要件
バイオマーカーに基づく臨床試験：試験のデザインおよび規制上の要件 はじめに 分子診断の分野では最近の開
序文 – Medical Education Clinical Trials Part I
序文 – Medical Education Clinical Trials Part I Nik Z
Ethical considerations in clinical trials, and responsibilities of a principal investigator
Ethical considerations in clinical trials, and r
Biomarker-based clinical trials: study design and regulatory requirements
Biomarker-based clinical trials: study design an
Preface – Part 1
Preface – Part 1 Nik Zeps PhD, St. John of Go
通过多种作用机制提高PARP抑制剂活性
通过多种作用机制提高PARP抑制剂活性 Hendrik-Tobias Arkenau，MD，PhD，F
